Founded in 1978, Biogen is a leading biotechnology company that pioneers innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities.
We apply deep understanding of human biology and leverage different modalities, to advance first-in-class treatments or therapies that deliver superior outcomes. Our approach is to take bold risks, balanced with return on investment to deliver long-term growth.
With approximately 7,000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, which is also home to our research operations. Our international headquarters are based in Baar, Switzerland and we have world-class manufacturing facilities in North Carolina and Solothurn, Switzerland. We offer therapies globally through direct affiliate presence in 30 countries and a network of distribution partners in over 50 additional countries.
For more information, please visit www.biogen.com. Follow us on social media – LinkedIn, Facebook, X, and YouTube.
Home | Biogen
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Speedinvest Venture Capital and Private Equity Principals | Other 31 Mar 2024 | | ||
Calcbench fintech, Financial Services | Other 25 Apr 2024 | | ||
ARSLA healthtech, Civic and Social Organizations | Other 5 Apr 2024 | | ||
1Health healthtech, Book and Periodical Publishing | Other 9 Apr 2024 | | ||
KCO Event Events Services | Other 1 Apr 2024 | | ||
Egualia – Industrie Farmaci Accessibili biotech, deeptech, Pharmaceutical Manufacturing | Other 3 Apr 2024 | | ||
APA de Géant, Maison Sport Santé healthtech, Wellness and Fitness Services | Other 2 Apr 2024 | | ||
Femmes de Santé healthtech, Wellness and Fitness Services | Other 7 May 2024 | | ||
Lys Therapeutics biotech, deeptech, Pharmaceutical Manufacturing | Other 22 Mar 2024 | | ||
Cumulus Neuroscience biotech, deeptech, healthtech, Biotechnology Research | Other 26 Feb 2024 | |